NTG dose for SCAPE. What should be bolus and infusion
Reading File
Searching the Web
NTG nitroglycerin bolus dose SCAPE sympathetic crashing acute pulmonary edema protocol
Searching PubMed
nitroglycerin bolus SCAPE acute pulmonary edema
Finding Sources
Searching PubMed
high dose nitroglycerin acute pulmonary edema emergency
Reading Article
Reading Article
Here is a full breakdown based on current evidence:
NTG Dosing for SCAPE
Why High-Dose?
Low-dose NTG (5-20 mcg/min) only reduces preload (venodilation). In SCAPE, the driving pathophysiology is a massive sympathetic surge causing severe afterload increase - you need >100 mcg/min to achieve arterial dilation and afterload reduction, which is the key to breaking the cycle.
Bolus
| Strategy | Dose | Rate |
|---|---|---|
| Standard bolus | 400-800 mcg IV | Over 1-2 min (= ~400 mcg/min for 2 min) |
| Aggressive bolus (Mathew et al.) | 600-1000 mcg IV | Over 2 min |
| Mean dose in studies | ~836-872 mcg | - |
- Can repeat bolus every 3-5 minutes if patient not responding and BP tolerates
- The 2021 Mathew prospective pilot study (n=25): mean bolus of 872 mcg, 0% hypotension, 96% avoided intubation
How to give it (standard 200 mcg/mL NTG bag):
- For 400 mcg/min x 2 min: set pump to 120 mL/hr, VTBI = 4 mL (delivers and stops)
Infusion
| Phase | Rate |
|---|---|
| Starting rate | 100-200 mcg/min |
| Titration target | Up to 400 mcg/min or higher as needed |
| Traditional (avoid in SCAPE) | 5-10 mcg/min - too low, won't work |
- Titrate every 3-5 min based on BP response and clinical improvement
- Stand at the bedside - these doses require direct monitoring
- Target: RR improving, SpO2 rising, patient coming off NIPPV
Evidence Summary
| Study | Design | Key Finding |
|---|---|---|
| Pramudyo et al. 2025 (BMJ Open) | Meta-analysis (4 studies, 185 pts) | HDN reduced intubation (RR 0.31), improved symptom resolution (RR 3.88), shorter stay - 0% hypotension in both groups |
| Siddiqua et al. 2024 (EMJ) | RCT (n=54) | 65% symptom resolution at 6h with HDN vs 11.5% low-dose (p<0.001), lower MACE, no serious AEs |
| Mathew et al. 2021 (PMID 34215472) | Prospective pilot | 600-1000 mcg bolus + 100 mcg/min infusion; 96% avoided intubation |
Practical Protocol (Mathew / EMCrit)
- NTG 600-1000 mcg IV bolus over 2 min
- Immediately start infusion at 100 mcg/min
- Titrate infusion up by 50-100 mcg/min every 3-5 min (to 200-400 mcg/min)
- Pair with NIPPV (BiPAP) - the combination is more effective than either alone
- Repeat bolus if minimal response at 3-5 min
Safety Notes
- Hypotension rate in high-dose protocols: ~0% in multiple prospective studies - the hypertensive/fluid-overloaded SCAPE patient tolerates this well
- Contraindications: hypotension, recent PDE5 inhibitor use (sildenafil/tadalafil), severe AS
- Don't use this dose in non-SCAPE AHF (normotensive/hypotensive decompensated HF)
- Always verify your hospital's NTG concentration before setting pump rates
This is a shared conversation. Sign in to Orris to start your own chat.